FATTIZZO, BRUNO
FATTIZZO, BRUNO
Dipartimento di Oncologia ed Emato-Oncologia
Deciphering cytopenias in internal medicine: a single-center observational study
2024 S. Leoni, M. Ferraresi, I. Motta, C. Hu, A.L. Fracanzani, W. Barcellini, B. Fattizzo
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?
2023 M. Riva, A. Bosi, L. Rizzo, F. Mazzon, S. Ferrari, F. Lussana, L. Borin, A. Castelli, R. Cairoli, W. Barcellini, A. Molteni, B. Fattizzo
Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis
2023 B. Fattizzo, F. Versino, M. Bortolotti, L. Rizzo, M. Riva, W. Barcellini
Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review
2023 B. Fattizzo, R. Pasquale, G.A. Croci, L. Pettine, G. Cassanello, W. Barcellini
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers
2022 B. Fattizzo, S. Cantoni, J.A. Giannotta, L. Bandiera, R. Zavaglia, M. Bortolotti, W. Barcellini
Cell Population Data NE-WX, NE-FSC, LY-Y of Sysmex XN-9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study
2022 D. Di Luise, J.A. Giannotta, M. Ammirabile, V. De Zordi, S. Torricelli, S. Bottalico, M.L. Chiaretto, B. Fattizzo, A.C. Migliorini, F. Ceriotti
Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients
2022 L. Pettine, M. Bortolotti, B. Fattizzo, M.C. Da Vià, D. Consonni, A. Pompa, N. Bolli, L. Baldini
Editorial: Immunologic Mechanisms of Myeloid Neoplasms
2022 B. Fattizzo, M.C. Da Via, A.G. Kulasekararaj
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
2022 B. Fattizzo, G.V. Levati, J.A. Giannotta, G. Cassanello, L.M. Cro, A. Zaninoni, M. Barbieri, G.A. Croci, N. Revelli, W. Barcellini
A case of severe aplastic anaemia after SARS-CoV-2 vaccination
2021 N. Cecchi, J.A. Giannotta, W. Barcellini, B. Fattizzo
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
2021 M. Jalink, S. Berentsen, J.J. Castillo, S.P. Treon, M. Cruijsen, B. Fattizzo, R. Cassin, D. Fotiou, E. Kastritis, M. De Haas, L.E.M. Oosten, H. Frederiksen, A. Patriarca, S. D'Sa, J.M.I. Vos
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
2021 B. Fattizzo, J.A. Giannotta, N. Cecchi, W. Barcellini
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
2021 I. Motta, J. Alessandro Giannotta, M. Ferraresi, K. Barbullushi, N. Revelli, G. Graziadei, W. Barcellini, B. Fattizzo
Autoimmune complications in hematologic neoplasms
2021 W. Barcellini, J.A. Giannotta, B. Fattizzo
Infectious and thrombotic complications and their prognostic impact in patients with concomitant myeloid and lymphoid neoplasms : a single-center cohort study
2021 C. Bucelli, B. Fattizzo, D. Cattaneo, J.A. Giannotta, K. Barbullushi, R. Pasquale, E. Barozzi, M.C. Barbanti, L. Pettine, F.G. Rossi, G. Reda, W. Barcellini, L. Baldini, A. Iurlo
Mitapivat sulfate
2021 W. Barcellini, J.A. Giannotta, N. Cecchi, B. Fattizzo
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome?
2021 B. Fattizzo, F. Serpenti, W. Barcellini, C. Caprioli
Complement Mediated Hemolytic Anemias in the COVID-19 Era : Case Series and Review of the Literature
2021 B. Fattizzo, R. Pasquale, V. Bellani, W. Barcellini, A.G. Kulasekararaj
Recent insights into the role of the microbiome in malignant and benign hematologic diseases
2021 B. Fattizzo, F. Cavallaro, F. Folino, W. Barcellini
Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy
2021 D.L. Hansen, S. Berentsen, B. Fattizzo, P.L. Hansen, W. Barcellini, H. Frederiksen